Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MARKEL GROUP INC.MKL · Entity 3229 | Director | May 01, 2020 | May 04, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MARKEL GROUP INC.
Report date May 01, 2020 · Filed May 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,955.6956 |
Ending reported balance
After 2020-05-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2020-05-01 · Purchase · Acquired 1 · Balance 2,956.6956 Row 2 · 2020-05-01 · Purchase · Acquired 335 · Balance 3,291.6956 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $830.025 to $831.00, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Row 3 · 2020-05-01 · Purchase · Acquired 265 · Balance 3,556.6956 F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $831.040 to $831.630, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Row 4 · 2020-05-01 · Purchase · Acquired 288 · Balance 3,844.6956 F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $832.342 to $832.768, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Row 5 · 2020-05-01 · Purchase · Acquired 111 · Balance 3,955.6956 F4: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $833.400 to $834.00, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 926.079 |
Reported balance
Holding disclosure · report date 2020-05-01 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 926.079 F5: Beneficial ownership of securities is expressly disclaimed. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $830.025 to $831.00, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $831.040 to $831.630, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $832.342 to $832.768, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $833.400 to $834.00, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5: Beneficial ownership of securities is expressly disclaimed.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ARRIS International plc
Report date April 04, 2019 · Filed April 09, 2019
Section 16 reporting ended · disclosed 2019-04-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-04-04 transaction · row 1
1 source rowRow 1 · 2019-04-04 · Disposition to issuer · Disposed 50,750 · Balance 0 F1: Pursuant to the terms of that certain Bid Conduct Agreement (the "Acquisition Agreement") between ARRIS International plc ("ARRIS") and CommScope Holding Company, Inc. ("CommScope"), CommScope agreed to acquire all of the issued and to be issued Ordinary Shares of ARRIS (the "Acquisition") for $31.75 per Ordinary Share by means of a court-sanctioned scheme of arrangement (the "Scheme"). On April 4, 2019, at the effective time of the Scheme (the "Effective Time"), each Ordinary Share then outstanding was automatically transferred from ARRIS shareholders in accordance with the Scheme and the Acquisition Agreement to CommScope, and the ARRIS shareholders ceased to have any rights with respect to their Ordinary Shares, except their right to receive $31.75 per Ordinary Share. This represents shares disposed of upon consummation of the Acquisition. |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2019-07-01 | Direct | 0 |
Reported balance
After 2019-04-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-04-04 · Disposition to issuer · Disposed 6,500 · Balance 0 F2: At the Effective Time, the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting one year from the date of grant, were cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of restricted stock units being so cancelled and converted. |
| Deferred Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-04-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-04-04 · Disposition to issuer · Disposed 13,550 · Balance 0 F1: Pursuant to the terms of that certain Bid Conduct Agreement (the "Acquisition Agreement") between ARRIS International plc ("ARRIS") and CommScope Holding Company, Inc. ("CommScope"), CommScope agreed to acquire all of the issued and to be issued Ordinary Shares of ARRIS (the "Acquisition") for $31.75 per Ordinary Share by means of a court-sanctioned scheme of arrangement (the "Scheme"). On April 4, 2019, at the effective time of the Scheme (the "Effective Time"), each Ordinary Share then outstanding was automatically transferred from ARRIS shareholders in accordance with the Scheme and the Acquisition Agreement to CommScope, and the ARRIS shareholders ceased to have any rights with respect to their Ordinary Shares, except their right to receive $31.75 per Ordinary Share. This represents shares disposed of upon consummation of the Acquisition. F3: This holding does not have a date of expiration, but its receipt was deferred until owner's separation from ARRIS. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of that certain Bid Conduct Agreement (the "Acquisition Agreement") between ARRIS International plc ("ARRIS") and CommScope Holding Company, Inc. ("CommScope"), CommScope agreed to acquire all of the issued and to be issued Ordinary Shares of ARRIS (the "Acquisition") for $31.75 per Ordinary Share by means of a court-sanctioned scheme of arrangement (the "Scheme"). On April 4, 2019, at the effective time of the Scheme (the "Effective Time"), each Ordinary Share then outstanding was automatically transferred from ARRIS shareholders in accordance with the Scheme and the Acquisition Agreement to CommScope, and the ARRIS shareholders ceased to have any rights with respect to their Ordinary Shares, except their right to receive $31.75 per Ordinary Share. This represents shares disposed of upon consummation of the Acquisition.
F2: At the Effective Time, the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting one year from the date of grant, were cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of restricted stock units being so cancelled and converted.
F3: This holding does not have a date of expiration, but its receipt was deferred until owner's separation from ARRIS.
Internap Corp
Report date May 08, 2020 · Filed May 08, 2020
Section 16 reporting ended · disclosed 2020-05-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-05-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-05-08 · Other · Disposed 123,028 · Balance 0 F1: As previously disclosed, on March 16, 2020, Internap Corporation (the "Company") and certain subsidiaries (the "Debtors") filed voluntary petitions for relief (collectively, the "Chapter 11 Cases") under Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York, White Plains Division (the "Bankruptcy Court"). On May 5, 2020, the Bankruptcy Court entered an order, which approved and confirmed the Debtors' First Amended Joint Prepackaged Chapter 11 Plan (the "Plan"). On May 8, 2020 (the "Effective Date"), the Debtors satisfied the conditions to effectiveness of the Plan and emerged from their Chapter 11 Cases. F2: Pursuant to the terms of the respective equity award agreements, immediately prior to the Effective Date, the restrictions on all outstanding restricted stock lapsed and all outstanding restricted stock units vested and shares of the Company's common stock, par value $0.001 per share (the "Common Stock") were issued in accordance with such equity award agreements. F3: In connection with the effectiveness of the Plan, all previously issued and outstanding Common Stock was canceled and extinguished. |
| Call Options (obligation to sell)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-05-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-05-08 · Other · Disposed 4,072 · Balance 0 F4: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled. |
Filing footnotes · ownership attribution and instrument terms
F1: As previously disclosed, on March 16, 2020, Internap Corporation (the "Company") and certain subsidiaries (the "Debtors") filed voluntary petitions for relief (collectively, the "Chapter 11 Cases") under Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York, White Plains Division (the "Bankruptcy Court"). On May 5, 2020, the Bankruptcy Court entered an order, which approved and confirmed the Debtors' First Amended Joint Prepackaged Chapter 11 Plan (the "Plan"). On May 8, 2020 (the "Effective Date"), the Debtors satisfied the conditions to effectiveness of the Plan and emerged from their Chapter 11 Cases.
F2: Pursuant to the terms of the respective equity award agreements, immediately prior to the Effective Date, the restrictions on all outstanding restricted stock lapsed and all outstanding restricted stock units vested and shares of the Company's common stock, par value $0.001 per share (the "Common Stock") were issued in accordance with such equity award agreements.
F3: In connection with the effectiveness of the Plan, all previously issued and outstanding Common Stock was canceled and extinguished.
F4: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2020 Filed May 8, 2020 16:40 UTC | Internap Corp INAPQ · Entity 149167 | OtherCall Options (obligation to sell) · Derivative | 4,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-007235 · wf-form4_158897043127006.xml · derivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Call Options (obligation to sell) · 4,072 shares Expires not disclosed F4 · derivative.exercise_price: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled. F4 · derivative.exercise_date: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled. F4 · derivative.expiration_date: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled. Read SEC document |
| May 08, 2020 Filed May 8, 2020 16:40 UTC | Internap Corp INAPQ · Entity 149167 | OtherCommon Stock | 123,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-007235 · wf-form4_158897043127006.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: As previously disclosed, on March 16, 2020, Internap Corporation (the "Company") and certain subsidiaries (the "Debtors") filed voluntary petitions for relief (collectively, the "Chapter 11 Cases") under Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York, White Plains Division (the "Bankruptcy Court"). On May 5, 2020, the Bankruptcy Court entered an order, which approved and confirmed the Debtors' First Amended Joint Prepackaged Chapter 11 Plan (the "Plan"). On May 8, 2020 (the "Effective Date"), the Debtors satisfied the conditions to effectiveness of the Plan and emerged from their Chapter 11 Cases. F2 · security: Pursuant to the terms of the respective equity award agreements, immediately prior to the Effective Date, the restrictions on all outstanding restricted stock lapsed and all outstanding restricted stock units vested and shares of the Company's common stock, par value $0.001 per share (the "Common Stock") were issued in accordance with such equity award agreements. F3 · security: In connection with the effectiveness of the Plan, all previously issued and outstanding Common Stock was canceled and extinguished. Read SEC document |
| May 01, 2020 Filed May 4, 2020 21:46 UTC | MARKEL GROUP INC. MKL · Entity 3229 | PurchaseCommon Stock | 111 | $833.44 | $92,511.51 |
DisclosureSEC source: 0001096343-20-000070 · wf-form4_158862879890046.xml · nonDerivative · entry 5 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,955.6956 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $833.400 to $834.00, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2020 Filed May 4, 2020 21:46 UTC | MARKEL GROUP INC. MKL · Entity 3229 | PurchaseCommon Stock | 288 | $832.69 | $239,813.57 |
DisclosureSEC source: 0001096343-20-000070 · wf-form4_158862879890046.xml · nonDerivative · entry 4 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,844.6956 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $832.342 to $832.768, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2020 Filed May 4, 2020 21:46 UTC | MARKEL GROUP INC. MKL · Entity 3229 | PurchaseCommon Stock | 265 | $831.54 | $220,357.04 |
DisclosureSEC source: 0001096343-20-000070 · wf-form4_158862879890046.xml · nonDerivative · entry 3 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,556.6956 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $831.040 to $831.630, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2020 Filed May 4, 2020 21:46 UTC | MARKEL GROUP INC. MKL · Entity 3229 | PurchaseCommon Stock | 335 | $830.90 | $278,352.17 |
DisclosureSEC source: 0001096343-20-000070 · wf-form4_158862879890046.xml · nonDerivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,291.6956 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $830.025 to $831.00, inclusive. The reporting person undertakes to provide to any security holder of Markel Corporation or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2020 Filed May 4, 2020 21:46 UTC | MARKEL GROUP INC. MKL · Entity 3229 | PurchaseCommon Stock | 1 | $828.68 | $828.68 |
DisclosureSEC source: 0001096343-20-000070 · wf-form4_158862879890046.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,956.6956 Read SEC document |
| March 16, 2020 Filed Mar 16, 2020 20:49 UTC | MARKEL GROUP INC. MKL · Entity 3229 | OtherCommon Stock | 9.1972 | $955.46 | $8,787.56 |
DisclosureSEC source: 0001096343-20-000045 · wf-form4_158439173433250.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,955.6956 F1 · kind: Shares acquired pursuant to, or bonus shares granted under, the Markel Corporation Employee Stock Purchase and Bonus Plan. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 16:19 UTC | Internap Corp INAP · Entity 149167 | GrantCommon Stock | 26,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007856 · wf-form4_156019794850469.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,028 F1 · security: Reporting Person received the restricted stock for annual director retainer. F2 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant. F3 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:34 UTC | MARKEL GROUP INC. MKL · Entity 3229 | OtherCommon Stock | 91.9726 | $1,032.92 | $95,000.34 |
DisclosureSEC source: 0001096343-19-000142 · wf-form4_155795247445561.xml · nonDerivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,946.4984 F2 · kind: Shares acquired pursuant to, or bonus shares granted under, the Markel Corporation Employee Stock Purchase and Bonus Plan. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:34 UTC | MARKEL GROUP INC. MKL · Entity 3229 | GrantCommon Stock | 121 | $0.00 | $0.00 |
DisclosureSEC source: 0001096343-19-000142 · wf-form4_155795247445561.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,854.5258 F1 · kind: Restricted stock granted pursuant to the Markel Corporation 2016 Equity Incentive Compensation Plan. Shares will vest May 13, 2020. Read SEC document |
| April 04, 2019 Filed Apr 9, 2019 16:00 UTC | ARRIS International plc ARRS · Entity 158436 | Disposition to issuerDeferred Ordinary Shares · Derivative | 13,550 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-19-015079 · form4.xml · derivative · entry 3 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,550 shares Expires not disclosed F1 · price: Pursuant to the terms of that certain Bid Conduct Agreement (the "Acquisition Agreement") between ARRIS International plc ("ARRIS") and CommScope Holding Company, Inc. ("CommScope"), CommScope agreed to acquire all of the issued and to be issued Ordinary Shares of ARRIS (the "Acquisition") for $31.75 per Ordinary Share by means of a court-sanctioned scheme of arrangement (the "Scheme"). On April 4, 2019, at the effective time of the Scheme (the "Effective Time"), each Ordinary Share then outstanding was automatically transferred from ARRIS shareholders in accordance with the Scheme and the Acquisition Agreement to CommScope, and the ARRIS shareholders ceased to have any rights with respect to their Ordinary Shares, except their right to receive $31.75 per Ordinary Share. This represents shares disposed of upon consummation of the Acquisition. F1 · derivative.exercise_date: Pursuant to the terms of that certain Bid Conduct Agreement (the "Acquisition Agreement") between ARRIS International plc ("ARRIS") and CommScope Holding Company, Inc. ("CommScope"), CommScope agreed to acquire all of the issued and to be issued Ordinary Shares of ARRIS (the "Acquisition") for $31.75 per Ordinary Share by means of a court-sanctioned scheme of arrangement (the "Scheme"). On April 4, 2019, at the effective time of the Scheme (the "Effective Time"), each Ordinary Share then outstanding was automatically transferred from ARRIS shareholders in accordance with the Scheme and the Acquisition Agreement to CommScope, and the ARRIS shareholders ceased to have any rights with respect to their Ordinary Shares, except their right to receive $31.75 per Ordinary Share. This represents shares disposed of upon consummation of the Acquisition. F3 · derivative.expiration_date: This holding does not have a date of expiration, but its receipt was deferred until owner's separation from ARRIS. Read SEC document |
| April 04, 2019 Filed Apr 9, 2019 16:00 UTC | ARRIS International plc ARRS · Entity 158436 | Disposition to issuerRestricted Shares · Derivative | 6,500 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-19-015079 · form4.xml · derivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,500 shares Expires 2019-07-01 F2 · price: At the Effective Time, the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting one year from the date of grant, were cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of restricted stock units being so cancelled and converted. F2 · derivative.exercise_date: At the Effective Time, the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting one year from the date of grant, were cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of restricted stock units being so cancelled and converted. Read SEC document |
| April 04, 2019 Filed Apr 9, 2019 16:00 UTC | ARRIS International plc ARRS · Entity 158436 | Disposition to issuerOrdinary Shares | 50,750 | $31.75 | $1,611,312.50 |
DisclosureSEC source: 0001127602-19-015079 · form4.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the terms of that certain Bid Conduct Agreement (the "Acquisition Agreement") between ARRIS International plc ("ARRIS") and CommScope Holding Company, Inc. ("CommScope"), CommScope agreed to acquire all of the issued and to be issued Ordinary Shares of ARRIS (the "Acquisition") for $31.75 per Ordinary Share by means of a court-sanctioned scheme of arrangement (the "Scheme"). On April 4, 2019, at the effective time of the Scheme (the "Effective Time"), each Ordinary Share then outstanding was automatically transferred from ARRIS shareholders in accordance with the Scheme and the Acquisition Agreement to CommScope, and the ARRIS shareholders ceased to have any rights with respect to their Ordinary Shares, except their right to receive $31.75 per Ordinary Share. This represents shares disposed of upon consummation of the Acquisition. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 20:39 UTC | MARKEL GROUP INC. MKL · Entity 3229 | OtherCommon Stock | 8.392 | $954.92 | $8,013.69 |
DisclosureSEC source: 0001096343-19-000095 · wf-form4_155250956141336.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,733.5258 F1 · kind: Shares acquired pursuant to, or bonus shares granted under, the Markel Corporation Employee Stock Purchase and Bonus Plan. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 21:39 UTC | MARKEL GROUP INC. MKL · Entity 3229 | OtherCommon Stock | 7.8574 | $1,039.00 | $8,163.84 |
DisclosureSEC source: 0001096343-19-000008 · wf-form4_154724272921979.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,651.2128 F1 · shares: Shares acquired pursuant to, or bonus shares granted under, the Markel Corporation Employee Stock Purchase and Bonus Plan. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 16:23 UTC | Internap Corp INAP · Entity 149167 | PurchaseCommon Stock | 7,000 | $7.19 | $50,330.00 |
DisclosureSEC source: 0001628280-18-013997 · wf-form4_154171216507734.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,302 F1 · security: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.17 to $7.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 20:02 UTC | Internap Corp INAP · Entity 149167 | GrantCommon Stock | 808 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-012225 · wf-form4_153852494711198.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,302 F1 · security: Reporting Person received restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock is awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 17:02 UTC | ARRIS International plc ARRS · Entity 158436 | PurchaseOrdinary Shares | 4,000 | $24.35 | $97,400.00 |
DisclosureSEC source: 0001127602-18-025485 · form4.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,750 Read SEC document |
| August 02, 2018 Filed Feb 27, 2019 21:34 UTC | MARKEL GROUP INC. MKL · Entity 3229 | GiftCommon Stock | 926.079 | $0.00 | $0.00 |
DisclosureSEC source: 0001096343-19-000067 · wf-form4_155130322684671.xml · nonDerivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 926.079 F1 · kind: This transaction involved a gift of securities by Ms. Wilson to an irrevocable trust for the benefit of her spouse and children. Ms. Wilson's spouse and daughter are the trustees of the trust. F2 · ownership.nature: Beneficial ownership of securities is expressly disclaimed. Read SEC document |
| August 02, 2018 Filed Feb 27, 2019 21:34 UTC | MARKEL GROUP INC. MKL · Entity 3229 | GiftCommon Stock | 926.079 | $0.00 | $0.00 |
DisclosureSEC source: 0001096343-19-000067 · wf-form4_155130322684671.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,725.1338 F1 · kind: This transaction involved a gift of securities by Ms. Wilson to an irrevocable trust for the benefit of her spouse and children. Ms. Wilson's spouse and daughter are the trustees of the trust. Read SEC document |
| July 01, 2018 Filed Jul 3, 2018 17:26 UTC | ARRIS International plc ARRS · Entity 158436 | GrantRestricted Shares · Derivative | 6,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-022705 · form4.xml · derivative · entry 3 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Ordinary Shares · 6,500 shares Expires not disclosed F2 · shares: Represents a restricted stock unit grant which fully vests one year from the grant date. F2 · derivative.exercise_date: Represents a restricted stock unit grant which fully vests one year from the grant date. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 21:13 UTC | Internap Corp INAP · Entity 149167 | GrantCommon Stock | 804 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-009105 · wf-form4_153066676967017.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,494 F1 · security: Reporting Person received restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock is awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 17:26 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionRestricted Shares · Derivative | 5,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-022705 · form4.xml · derivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to ordinary shares. F2 · derivative.exercise_date: Represents a restricted stock unit grant which fully vests one year from the grant date. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 17:26 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionOrdinary Shares | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-022705 · form4.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to ordinary shares. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 17:15 UTC | Internap Corp INAP · Entity 149167 | GrantCommon Stock | 9,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-007796 · wf-form4_152875172828529.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,690 F1 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 24, 2018 Filed May 25, 2018 16:25 UTC | Internap Corp INAP · Entity 149167 | PurchaseCommon Stock | 2,500 | $9.76 | $24,400.00 |
DisclosureSEC source: 0001628280-18-007226 · wf-form4_152727989533779.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,133 Read SEC document |
| May 16, 2018 Filed May 16, 2018 22:09 UTC | MARKEL GROUP INC. MKL · Entity 3229 | OtherCommon Stock | 83.92 | $1,132.03 | $95,000.03 |
DisclosureSEC source: 0001096343-18-000116 · wf-form4_152650853996026.xml · nonDerivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,643.3554 F2 · shares: Shares acquired pursuant to, or bonus shares granted under, the Markel Corporation Employee Stock Purchase and Bonus Plan. Read SEC document |
| May 14, 2018 Filed May 16, 2018 22:09 UTC | MARKEL GROUP INC. MKL · Entity 3229 | GrantCommon Stock | 110 | $0.00 | $0.00 |
DisclosureSEC source: 0001096343-18-000116 · wf-form4_152650853996026.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,559.4354 F1 · shares: Restricted stock granted pursuant to the Markel Corporation 2016 Equity Incentive Compensation Plan. Shares will vest May 14, 2019. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 16:20 UTC | Internap Corp INAP · Entity 149167 | GrantCommon Stock | 624 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-003944 · wf-form4_152278676589910.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,633 F1 · security: Reporting Person received restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock are awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 16:35 UTC | ARRIS International plc ARRS · Entity 158436 | PurchaseOrdinary Shares | 2,000 | $25.17 | $50,330.00 |
DisclosureSEC source: 0001415889-18-000287 · form4-02212018_040202.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,050 Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 16:28 UTC | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 398 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-000091 · wf-form4_151501492556652.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,009 F1 · security: Reporting Person has elected to receive restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock are awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. F3 · balance_after: On November 20, 2017, the Issuer effected a 1-for-4 reverse stock split of its Common Stock. The amount of securities reported as beneficially owned in this Form 4 has been adjusted to reflect the reverse stock split. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 16:49 UTC | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-009636 · wf-form4_150706372653747.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,449 F1 · security: Reporting Person has elected to receive restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock are awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 07, 2017 Filed Jul 11, 2017 20:30 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionRestricted Shares (T) 160707 · Derivative | 7,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001173 · form4-07112017_080733.xml · derivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Represents a restricted stock grant which fully vests one year from the grant date. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| July 07, 2017 Filed Jul 11, 2017 20:30 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionOrdinary Shares | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001173 · form4-07112017_080733.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to ordinary shares. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 20:30 UTC | ARRIS International plc ARRS · Entity 158436 | GrantRestricted Shares (T) 170701 · Derivative | 5,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001132 · form4-07052017_080715.xml · derivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700 Underlying: Ordinary Shares · 5,700 shares Expires not disclosed F1 · security: Represents a restricted stock grant which fully vests one year from the grant date. F2 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 09:19 UTC | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 32,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041521 · doc4.xml · nonDerivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,012 F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. F3 · security: One hundred percent of the shares of restricted common stock will vest on the date of the issuer's annual meeting of stockholders to be held in 2018. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 09:19 UTC | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 3,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041521 · doc4.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,754 F1 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 21, 2017 Filed Aug 24, 2017 18:11 UTC Amendment | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 32,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-008883 · wf-form4a_150361266519048.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,012 F1 · security: The Form 4 originally filed on June 23, 2017 incorrectly reported the vesting period for the Restricted Common Stock. This amendment reports the correct vesting period for the Restricted Common Stock, which is one hundred percent of the shares vest on the one year anniversary of the date of grant. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:39 UTC | MARKEL GROUP INC. MKL · Entity 3229 | OtherCommon Stock | 78.5745 | $954.51 | $75,000.15 |
DisclosureSEC source: 0001096343-17-000093 · wf-form4_149497076898726.xml · nonDerivative · entry 2 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,449.4354 F2 · shares: Shares acquired pursuant to, or bonus shares granted under, the Markel Corporation Employee Stock Purchase and Bonus Plan. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:39 UTC | MARKEL GROUP INC. MKL · Entity 3229 | GrantCommon Stock | 105 | $0.00 | $0.00 |
DisclosureSEC source: 0001096343-17-000093 · wf-form4_149497076898726.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,370.8609 F1 · shares: Restricted stock granted pursuant to the Markel Corporation 2016 Equity Incentive Compensation Plan. Shares will vest May 15, 2018. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 17:59 UTC | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 616 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026339 · doc4.xml · nonDerivative · entry 1 WILSON DEBORA J · CIK 0001257161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,394 F1 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.